The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

Recep Tayyip Erdogan University Training and Research Hospital

Status: Completed

Conditions: Bronchiectasis Adult; Asthma COPD; Tobacco Cessation

Treatments: Other: Immediate smoking cessation support

Study type: Interventional

Funder types: Other

Identifiers

NCT05764343

EKGG

Details and patient eligibility

About

Smoking cessation support is provided by smoking cessation outpatient clinics in our country. Smokers with chronic airway diseases can also apply to these services by making an appointment from quit lines. Quit rates of that group patients were found to be similar to the general population. In novel smoking cessation support approaches immediate cessation support is reported to be more effective than routine practice. The sample in these studies consists of individuals who applied for lung health screening programmes. There is no study in the literature examining the effect of this immediate support on patients with chronic airway diseases' quit success. Our aim with this study is to examine impact of immediate cessation support by getting an appointment to the same cessation clinic instantly on our sample's cessation success.

Full description

Patients who are current smokers (who have smoked at least 100 cigarettes in their lifetime and still smoke daily or some days) will be randomized in a 1:1 ratio to the two arms in sequential order of presentation, after they have been identified and given written informed consent about the study. Demographic and clinical features will be filled. A brief smoking cessation intervention will be applied to one group and they will be recommended to apply to smoking cessation outpatient clinics by obtaining appointment from quit lines, as the way of current routine practice. Those randomized to the other group will have an immediate appointment at the smoking cessation outpatient clinic in addition to the brief smoking cessation intervention. Both patient groups will be called after 1 week by phone to inquire about their smoking cessation status and their application to smoking cessation outpatient clinics. Both groups will be called again in the 3rd month and their smoking cessation status, their application to smoking cessation outpatient clinics, and the duration/status of using pharmacological smoking cessation treatments will be questioned.

Enrollment: 397 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Being age 18 years and over,
2. Having diagnoses of asthma and/or COPD and/or bronchiectasis for at least 6 months,
3. Applying to the chest diseases outpatient clinics,
4. Being an current smoker,
5. Those who agree to participate in the study,
6. Patients who can be reached by phone calls at 1 week and 3 months after randomization.

Exclusion criteria

1. Those with active psychiatric disorders
2. Patients with impaired cognitive functions.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

397 participants in 2 patient groups

Routine support/care arm

No Intervention group

Description:

As the followed routine implementation, this group will be given a brief smoking cessation intervention and will be recommended to apply to smoking cessation outpatient clinics by getting an appointment from quit services.

Immediate support arm

Active Comparator group

Description:

Those randomized to this group will have an immediate appointment at the smoking cessation outpatient clinic in addition to the brief smoking cessation intervention.

Treatment:

Other: Immediate smoking cessation support